Lyfgen Pharmaceuticals Private Limited
About Lyfgen Pharmaceuticals Private Limited
Data last updated:
Lyfgen Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2018PTC337865. Its GSTIN is 10AADCL6889N1ZZ (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Anita Kumari and Shailendra Kumar.
Its last annual general meeting (AGM) was held on 31 December 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 144 3rd Floor Sant Nagar East Of Kailash New Delhi, Delhi, India – 110065.
As per the financials filed for FY 2021, the company reported a revenue of ₹16.12 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net loss of ₹20,972 (net margin -1.3%) and EBITDA of ₹23,198 (EBITDA margin 1.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address144 3rd Floor Sant Nagar East Of Kailash New Delhi, Delhi, India – 110065
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lyfgen Pharmaceuticals Private Limited
The main business activity of Lyfgen Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lyfgen Pharmaceuticals Private Limited FY 2021 filings available
Lyfgen Pharmaceuticals Private Limited reported revenue of ₹16.12 Lakh (up 43% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR) of Lyfgen Pharmaceuticals Private Limited
Revenue rose 43% in the latest year. EBITDA rose 118% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Lyfgen Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹23,198 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹20,972 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Lyfgen Pharmaceuticals Private Limited
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.4% | •••• | •••• |
| Net Profit Margin | -1.3% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lyfgen Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lyfgen Pharmaceuticals Private Limited
Lyfgen Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shuban Pharmaceuticals Private Limited | ₹16.17 Lakh (FY 2025) | •••• | •••• | 62.0% | •••• | Bhiwandi, Maharashtra, India |
| Vigilan Pharmaceuticals Private Limited | ₹16.15 Lakh (FY 2024) | •••• | •••• | 43.0% | •••• | Lucknow, Uttar Pradesh, India |
| Aashish Formulations Private Limited | ₹16.15 Lakh (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Aauris Healthcare Private Limited | ₹16.14 Lakh (FY 2025) | •••• | •••• | 1957.0% | •••• | Kolkata, West Bengal, India |
| Bensara Pharmaceuticals Private Limited | ₹16.13 Lakh (FY 2024) | •••• | •••• | -57.0% | •••• | Navi Mumbai, Maharashtra, India |
| Lyfgen Pharmaceuticals Private Limited this company | ₹16.12 Lakh (FY 2021) | •••• | •••• | 43.0% | •••• | New Delhi, Delhi, India |
| Vacto Clip Pharmaceuticals Private Limited | ₹16.08 Lakh (FY 2024) | •••• | •••• | -8.0% | •••• | Paraganas, West Bengal, India |
| Morris Mark Pharmaceuticals Private Limited | ₹16.08 Lakh (FY 2025) | •••• | •••• | 60.0% | •••• | Wayanad, Kerala, India |
| Novetra Laboratories Private Limited | ₹16.04 Lakh (FY 2025) | •••• | •••• | 6460.0% | •••• | Thane, Maharashtra, India |
| Shantakaram Pharmaceuticals Private Limited | ₹16.02 Lakh (FY 2024) | •••• | •••• | -66.0% | •••• | Gwalior, Madhya Pradesh, India |
| Treatsoul Pharmaceuticals Private Limited | ₹16.01 Lakh (FY 2025) | •••• | •••• | 182.0% | •••• | Palanpur, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Lyfgen Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Lyfgen Pharmaceuticals Private Limited
Lyfgen Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Kumari | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
| Shailendra Kumar | Director | 27 Aug 2018 | 8 Years 1 Months | Current |
Ownership and Shareholding of Lyfgen Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Lyfgen Pharmaceuticals Private Limited
Lyfgen Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lyfgen Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Lyfgen Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Lyfgen Pharmaceuticals Private Limited
Lyfgen Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anita Kumari was appointed as Director on 27 Aug 2018.
Credit Ratings, Litigation & Regulatory Alerts for Lyfgen Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lyfgen Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lyfgen Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lyfgen Pharmaceuticals Private Limited
Lyfgen Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AADCL6889N1ZZ | Bihar | Active | 07 Nov 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lyfgen Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lyfgen Pharmaceuticals Private Limited
Lyfgen Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 August 2018 (8+ years old) and is registered under CIN U33100DL2018PTC337865.
Lyfgen Pharmaceuticals reported revenue of ₹16.12 Lakh for FY 2021 (up 43% YoY).
Lyfgen Pharmaceuticals has 2 current directors:
- Anita Kumari - Director
- Shailendra Kumar - Director
Lyfgen Pharmaceuticals reported a net loss of ₹20,972 (net margin -1.3%) and EBITDA of ₹23,198 (EBITDA margin 1.4%) for FY 2021, as per its filed financial statements.
The GSTIN of Lyfgen Pharmaceuticals is 10AADCL6889N1ZZ, registered in Bihar.
The CIN (Corporate Identification Number) of Lyfgen Pharmaceuticals is U33100DL2018PTC337865. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lyfgen Pharmaceuticals was incorporated on 27 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lyfgen Pharmaceuticals by revenue are Shuban Pharmaceuticals Private Limited, Vigilan Pharmaceuticals Private Limited, Aashish Formulations Private Limited, Aauris Healthcare Private Limited, Bensara Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Anita Kumari was appointed as Director on 27 Aug 2018. Shailendra Kumar was appointed as Director on 27 Aug 2018.
The registered office of Lyfgen Pharmaceuticals is at 144 3rd Floor Sant Nagar East Of Kailash New Delhi, Delhi, India – 110065.
Lyfgen Pharmaceuticals has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh.